Envista Holdings Corp (NVST) FinancialsNVSTEnvista Holdings Corp

Envista Holdings Corporation (NVST) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Specialty Products & Technologies, accounting for 64.9% of total sales, equivalent to $457.80M. Another important revenue stream is Equipment & Consumables. Understanding this composition is critical for investors evaluating how NVST navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Envista Holdings Corporation maintains a gross margin of 56.71%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.11%, while the net margin is 7.35%. These profitability ratios, combined with a Return on Equity (ROE) of 3.06%, provide a clear picture of how effectively NVST converts its operational activities into shareholder value.

In the context of the broader market, NVST competes directly with industry leaders such as VCYT and IRTC. With a market capitalization of $3.65B, it holds a leading position in the sector. When comparing efficiency, NVST's gross margin of 56.71% stands against VCYT's 71.93% and IRTC's 72.80%. Such benchmarking helps identify whether Envista Holdings Corporation is trading at a premium or discount relative to its financial performance.

Envista has shown strong revenue growth, with Q2 2026 revenue at $730.5 million and a gross margin of 56.71%. The latest EPS was $0.41, beating estimates by 24.24%.